Among major human acute myeloid leukemias (AMLs), MLL-rearranged AML (MLL-AML) is characteristic of poor prognosis due to refractoriness to chemotherapy and shorter period to relapse [1–3]. Here, KMT2A is linked to acute myeloid leukemia.